Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Adjuvant Therapy
Combined estrogen/antipsychotic therapy doesn't prevent relapse in females
May 5th, 2005
Using estrogen as adjuvant therapy to antipsychotics doesn't prevent relapse in female schizophrenia patients, study results show. University of Heidelberg psychiatrists conducted a multicenter, randomized, placebo-controlled, double-blind, cross-over study of "estrogen as an adjunct treatment to antipsychotics in women suffering from schizophrenia for relapse prevention." The study was "based on an A-B-A-B (and/or B-A-B-A) design," said N. Bergemann and colleagues. "Forty-six hypestrogenic women with schizophrenia hospitalized for the first time or repeatedly were included in the study. Their average age was 37.9 and they had...
Source: Women's Health Weekly (2005-05-05)
|
